Skip to main content
Premium Trial:

Request an Annual Quote

'Fauxpen' Data

Dorothea at Book of Trogool is tired of "fauxpen" access to data. "It's pretty safe to say ... that the Cacao Genome Project ain't open data," she says, pointing to Glen Newton's post on the Mars-led sequencing project. Newton says that in order to access data from the Cacao Genome Project, "you have to get an account — no anonymous access; obligatory registration is pretty counter-Open Access," and that "in order to get an account, you have to agree to a license," which restricts users' use of the data. Dorothea says that this misuse of the term "open" may not have been the researchers' fault. "Maybe somebody’s lawyer wasn't clear on the concept. ... Maybe somebody's Web site developer was asleep at the switch," Dorothea writes, adding that she won't "assume malice or cluelessness until more is known." Irrespective of the circumstances behind it, Dorothea says that the cacao genome team's claim is telling of the "brand value of 'open,'" especially as it pertains to genomic data.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.